TR199903072T2 - Diabetin tiazolidinedion ve alfa-glukosidaz ile tedavisi. - Google Patents

Diabetin tiazolidinedion ve alfa-glukosidaz ile tedavisi.

Info

Publication number
TR199903072T2
TR199903072T2 TR1999/03072T TR9903072T TR199903072T2 TR 199903072 T2 TR199903072 T2 TR 199903072T2 TR 1999/03072 T TR1999/03072 T TR 1999/03072T TR 9903072 T TR9903072 T TR 9903072T TR 199903072 T2 TR199903072 T2 TR 199903072T2
Authority
TR
Turkey
Prior art keywords
treatment
alpha
diabetes
thiazolidinedione
glucosidase
Prior art date
Application number
TR1999/03072T
Other languages
English (en)
Turkish (tr)
Inventor
Alistair Smith Stephen
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712865.6A external-priority patent/GB9712865D0/en
Priority claimed from GBGB9806708.5A external-priority patent/GB9806708D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of TR199903072T2 publication Critical patent/TR199903072T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR1999/03072T 1997-06-18 1998-06-15 Diabetin tiazolidinedion ve alfa-glukosidaz ile tedavisi. TR199903072T2 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9712865.6A GB9712865D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
GBGB9806708.5A GB9806708D0 (en) 1998-03-27 1998-03-27 Novel method

Publications (1)

Publication Number Publication Date
TR199903072T2 true TR199903072T2 (xx) 2000-07-21

Family

ID=26311746

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03072T TR199903072T2 (xx) 1997-06-18 1998-06-15 Diabetin tiazolidinedion ve alfa-glukosidaz ile tedavisi.

Country Status (24)

Country Link
EP (1) EP0975343A1 (no)
JP (1) JP2001523271A (no)
KR (1) KR20010013845A (no)
CN (1) CN1274282A (no)
AP (1) AP9901720A0 (no)
AR (2) AR013352A1 (no)
AU (1) AU8799998A (no)
BG (1) BG103966A (no)
BR (1) BR9810186A (no)
CA (1) CA2294134A1 (no)
CO (1) CO4940453A1 (no)
DZ (1) DZ2519A1 (no)
EA (1) EA200000040A1 (no)
IL (1) IL133138A0 (no)
MA (1) MA26510A1 (no)
NO (1) NO996270L (no)
NZ (1) NZ501345A (no)
OA (1) OA11631A (no)
PE (1) PE89199A1 (no)
PL (1) PL337577A1 (no)
SK (1) SK179499A3 (no)
TR (1) TR199903072T2 (no)
UY (1) UY25051A1 (no)
WO (1) WO1998057635A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000064892A2 (en) 1999-04-23 2000-11-02 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
CA2442917C (en) 2001-04-04 2011-02-01 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
DE60233655D1 (de) 2001-04-04 2009-10-22 Ortho Mcneil Janssen Pharm R und retinoid x rezeptorenmodulatoren
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
JP2004067575A (ja) * 2002-08-06 2004-03-04 Yaizu Suisankagaku Industry Co Ltd 糖尿病治療薬効果促進剤
CN101121004B (zh) * 2006-08-08 2010-07-21 鲁南制药集团股份有限公司 含有胰岛素增敏剂和米格列醇的药物组合物
CN101584688B (zh) * 2008-05-24 2010-11-10 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物
CN101584705B (zh) * 2008-05-24 2010-10-27 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0601001B1 (en) * 1991-08-26 1997-04-16 PHARMACIA & UPJOHN COMPANY Liquid food product containing 3-guanidinopropionic acid
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
EA200000040A1 (ru) 2000-08-28
CN1274282A (zh) 2000-11-22
JP2001523271A (ja) 2001-11-20
SK179499A3 (en) 2000-11-07
AR013352A1 (es) 2000-12-27
EP0975343A1 (en) 2000-02-02
PL337577A1 (en) 2000-08-28
CO4940453A1 (es) 2000-07-24
AR014881A1 (es) 2001-04-11
MA26510A1 (fr) 2004-12-20
NZ501345A (en) 2001-10-26
NO996270D0 (no) 1999-12-17
WO1998057635A1 (en) 1998-12-23
KR20010013845A (ko) 2001-02-26
BR9810186A (pt) 2000-08-08
AU8799998A (en) 1999-01-04
CA2294134A1 (en) 1998-12-23
AP9901720A0 (en) 1999-12-31
PE89199A1 (es) 1999-10-23
OA11631A (en) 2004-11-22
NO996270L (no) 1999-12-17
DZ2519A1 (fr) 2003-02-01
IL133138A0 (en) 2001-03-19
UY25051A1 (es) 2000-09-29
BG103966A (bg) 2000-07-31

Similar Documents

Publication Publication Date Title
TR199903057T2 (xx) Diabetin tiazolidinedion ve metformin ile tedavisi.
MXPA02012763A (es) Combinaciones de inhibidores de dipeptidil peptidasa iv y otros agentes antidiabeticos para el tratamiento de diabetes mellitus.
TR199903095T2 (xx) Diabetin roziglitazon ve ins�lin ile tedavisi.
TR200000134T2 (tr) Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi.
WO2001091774A3 (en) Method of treating chronic ulcers
TR199903072T2 (xx) Diabetin tiazolidinedion ve alfa-glukosidaz ile tedavisi.
AP2000001735A0 (en) Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor.
TR199903096T2 (xx) Diabetin tiazolidinedion ve s�lfonil�re ile tedavisi.
TR200101336T2 (tr) Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar
MY138246A (en) Treatment of diabetes with thiazolidione and sulphonylurea.
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
ECSP982541A (es) Nuevo metodo de tratamiento ii
HUP0002569A2 (hu) Diabetes kezelésére alkalmas dioxo-tiazolidint és alfa-glükozidáz inhibitort tartalmazó gyógyszerkészítmények
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
ECSP982542A (es) Nuevo metodo de tratamiento iii
ECSP982592A (es) Nuevo metodo de tratamiento v
ECSP982591A (es) Nuevo metodo de tratamiento iv